Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Iressa
Active Ingredient: Gefitinib 250mg
Dosage Form: Coated tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturer: AstraZeneca UK Limited, Macclesfield, Cheshire, United Kingdom
Note: This consent is valid for two years from 22 January 2006.
Dated this 10th day of October 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).